NCAM1 and thyroid gland papillary carcinoma: The papillary carcinoma uses thyroglobulin as a tumor marker which is highly sensitive but not specific, CD56 was used in one-third of the cases of papillary cancers where its negativity was highly sensitive, as it was not applied in other variants so specificity could not be assessed.